Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Allopartis Biosciences (AKA: Allopartis Biotechnologies)
Profile last edited on: 12/23/14      CAGE: 508S1      UEI:

Business Identifier: industrial and therapeutic proteins
Year Founded
2008
First Award
2009
Latest Award
2010
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

409 Illinois Street
San Francisco, CA 94158
   (415) 655-1694
   info@allopartis.com
   www.allopartis.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

Allopartis Biotechnologies, Inc. develops industrial and therapeutic proteins. It offers AlloZyme 8 for renewable chemical and biofuel production markets, which is produced by AlloScreen, an enzyme optimization platform that integrates emulsions, directed evolutions, and solid substrate particles. Allopartis Biotechnologies, Inc. operates as a subsidiary of Novozymes A/S.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$280,000
Phase II Dollars
$1,000,000
Total Awarded
$1,280,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 2 DOE $1,100,000
Project Title: High-Throughput Cellulase Evolution Against Pre-Treated Lignocellulosic Biomass
2009 1 USDA $80,000
Project Title: Improving Biochemical Conversion of Cellulosic Biomass for Sustainable Biofuel Production
2009 1 NSF $100,000
Project Title: Coupling High-throughput Evolution and Expression Screening for Industrial Production of Biofuel Enzymes

Key People / Management

  Robert Blazej -- President

  Richard Cohen -- Director of Analytics

  Charles Emrich -- Co-Founder and Chief Scientific Officer

  Nick Toriello -- Vice President of Operations

Company News

There are no news available.